EquityFlow
›
Companies
› Henlez
Henlez
Biotech
· Copenhagen, DK
Preclinical biotech developing enzyme-based drugs for skin diseases
Funding history
Date
Round
Amount
Oct 2022
Seed
Copenhagen biotech Henlez raised a EUR1M seed round from Eir Ventures and Karolinska Development to advance its lead skin-disease program.
$1.1M
Investors
Eir Ventures
Karolinska Development
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →